image117

Welcome

Serving the business needs of animal health companies to forge the future of therapeutics together. 

PRINCIPAL

Valentine S. Williams, DVM, MS, Diplomate ACVS

Professional Summary

Dr. Williams is a distinguished ‘out-of-the-box-thinking’ veterinarian with over twenty years of progressive success bridging functionality across early development, strategic project portfolio planning, FDA/USDA/EPA product approvals, commercial product launches, technical marketing, pharmacovigilance, quality, and training. She has expertise aligning business initiatives with industry needs, focusing on operational efficiency to meet business and investor milestones, and strategic execution of multiple complex projects. She is a champion of collaboration between academia and industry to enhance quality of medicine for customers and patients.


  

Education

Equine Surgery Residency and Board Certification, The Ohio State University, Columbus, OH

Master of Science Joint Physiology, The Ohio State University, Columbus, OH

Doctor of Veterinary Medicine, Summa Cum Laude, Texas A&M University, College Station, Tx

Bachelor of Science Veterinary Medicine, Cum Laude, Texas A&M University, College Station, Tx

Master of Science Reproductive Physiology, Colorado State University, Ft Collins, CO

Bachelor of Science Animal Science, Texas A&M University, College Station, Tx

PROFESSIONAL HIGHLIGHTS

Specialized in veterinary research, development, and commercialization for biologics (vaccines), pharmaceuticals, biologicals (monoclonal antibodies), and non-regulated products.

Ensures highest standards of professional ethics and animal welfare in compliance with regulations.

Effective at engaging and mentoring teams to ensure technical accuracy and regulatory compliance.

Expert at delivering strategy, scientific acumen, and brand support across species.

Distinguished presenter, speaker, and author with a reputation as an ‘out of the box thinker’ of high-quality science who engages audiences in thought provoking topics. Sought after for special projects.

Progressive multi-faceted leadership partnering with industry, practitioners, key opinion leaders, scientific advisory councils, and academia.

Excels at turning early ideas into applicable concepts, strategic planning, execution, and business results. 

Publications

  1.  Mason BL, Williams V, Hu T, Lee J, Poole M.  Double-blind, placebo-controlled, randomized study to evaluate the weight gain drug, mirtazapine transdermal ointment, in cats experiencing unintended weight loss:  A post-hoc analysis of cats with suspected kidney disease (oral presentation).  Presented at American College of Veterinary Internal Medicine Forum. Jun 6-8, 2019 (Phoenix, AZ). Presented at the American Association of Feline Practitioners. Oct 31 – Nov 3, 2019 (San Francisco, CA). 
  2. Mason BL, Williams V, Hu T, Lee J, Poole M.  Double-blind, placebo-controlled, randomized study to evaluate the weight gain drug, mirtazapine transdermal ointment, in cats experiencing unintended weight loss:  A post-hoc analysis of cats with suspected kidney disease (oral presentation). Presented at the American College of Veterinary Internal Medicine Forum. Jun 6-8, 2019 (Phoenix, AZ). 
  3. Mason BL, Williams V, Hu T, Lee J, Poole M.  Double-blind, placebo-controlled, randomized study to evaluate the weight gain drug, mirtazapine transdermal ointment, in cats experiencing unintended weight loss:  A post-hoc analysis of cats with suspected kidney disease (oral presentation).  Presented at the British Small Animal Veterinary Association.  Apr 4-7, 2019 (Birmingham, UK). 
  4. Buhles W, Quimby JM, Labelle D, Williams VS. Single and multiple dose pharmacokinetics of a novel mirtazapine transdermal ointment in cats. J Vet Pharmacol Ther. 2018;41(5):644-651.
  5. Williams V, Quimby J, Poole M, Lee J.  Assessment of exposure to topical drug residues from petting following repeated application of a novel mirtazapine transdermal ointment in cats.  AAFP.  October 19-22, 2017.  Denver, CO.
  6. Williams V. Safety of Tiludronate Disodium. AAEP Proceedings 2015.
  7. Williams V. and Allen K. Tiludronate Disodium in the Management of Lameness Associated with Equine Navicular Syndrome. AAEP Proceedings 2015.
  8. Williams V. Intra-articular Hyaluronic Acid in the Horse: The Importance of Molecular Weight. Journal of Equine Veterinary Science 2007;27(7):298-303.
  9. Moses V, Bertone A. Nonsteroidal Anti-inflammatory Drugs. Veterinary Clinics of North America: Equine Practice – Pain Management and Anesthesia, 2001.
  10. Moses V, Hardy J, Bertone A, Weisbrode S. Effects of anti-inflammatory drugs on lipopolysaccharide challenged and unchallenged equine synovial explants. American Journal of Veterinary Research 2001;62(1):54-60.
  11. Sadler V, Wisner E, Robertson J, Moses V. Atresia of the parotid salivary gland in a horse. Veterinary Radiology and Ultrasound 1999;40(3):259-261.
  12. Shabpareh V, Squires EL, Seidel GE, Jasko DJ. Methods for collecting and maturing equine oocytes in vitro. Theriogenology 1993;40:1161-1175.
  13. Shabpareh V, Squires EL, Cook VM, Cole R. An alternative lighting regimen to hasten the onset of the breeding season in mares. Equine Practice 1992;14(2):24-27.